ATUVIBI ConCiencia Grant 2026 for Biliary Tract Cancer Research
ATUVIBI ConCiencia Grant 2026 for Biliary Tract Cancer Research Oncodaily
Онкология
Исследования и наука
1636 материалов по теме, собраны автоматически из проверенных источников
🎗️
Онкология
Astellas Bets Up to $1.3 Billion on Cancer Drug Yet to Enter Human Trials
Astellas Bets Up to $1.3 Billion on Cancer Drug Yet to Enter Human Trials Bloomberg.com
Онкология
Rutgers Medical School Researcher Available to Discuss Study on Possible New Way to Fight Drug-Resistant Liver Cancer | Newswise
Rutgers Medical School Researcher Available to Discuss Study on Possible New Way to Fight Drug-Resistant Liver Cancer | Newswise Newswise
Онкология
Why cancer researchers struggle to capture the patient voice
Why cancer researchers struggle to capture the patient voice Fred Hutchinson Cancer Center
Онкология
Targeting fat-cell enzyme offers potential strategy to reduce obesity and cancer risk
Obesity touches countless lives across the country and can lead to many other health complications. From August 2021 to 2023, the prevalence of obesity in adults in the U.S. was more than 40%. Research published in Science Advances, led by scientists at VCU Massey Comprehensive Cancer Center, found that targeting fat…
Онкология
Alliance for Clinical Trials in Oncology Announced Phase III ShortStop HER2 Study
Alliance for Clinical Trials in Oncology Announced Phase III ShortStop HER2 Study Oncodaily
Онкология
After 3 cancer diagnoses, Kentucky woman becomes first in state to participate in groundbreaking neutropenia clinical trial
After 3 cancer diagnoses, Kentucky woman becomes first in state to participate in groundbreaking neutropenia clinical trial Norton Healthcare
Онкология
How blocking immune cell signals could make brain tumors easier to remove
In a new study published in Cancer Cell, researchers at VIB-KU Leuven reduced the spread of glioblastoma by interrupting specific interactions between the brain's immune cells and tumor cells. The discovery points to a possible new therapeutic strategy, in which blocking communication between immune and cancer cells…
Онкология
Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer
Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer The Boston Globe
Онкология
Pathology research identifies potential new target for preventing brain metastasis
Research led by professor of pathology Mikhail Nikiforov, Ph.D., has identified a key mechanism that helps cancer cells spread to the brain, which may lead to a new target for future therapies. The findings were published in the journal Cell Reports in the article "SERINC2-mediated phosphatidylserine remodeling…
Онкология
Seton Hall professor receives $100,000 cancer research grant
Seton Hall professor receives $100,000 cancer research grant The Setonian
Онкология
Highest endometrial cancer rates found in San Antonio region
An Upper-South region of Texas including San Antonio and Bexar County had the state's highest hysterectomy-corrected incidence of endometrial cancer and the largest increase over time, a study led by scientists at The University of Texas at San Antonio Health Science Center and the National Cancer Institute showed.
Онкология
Strengthening Cancer Prevention and Early Detection Through Research and Innovation - Youth Cancer Europe
Strengthening Cancer Prevention and Early Detection Through Research and Innovation - Youth Cancer Europe Oncodaily
Онкология
Glioblastoma's secret weapon: Silencing the brain's off switch
Researchers at Baylor College of Medicine have discovered a new strategy that glioblastoma, the most common and aggressive form of adult brain cancer, uses to fuel its own growth. Published in the journal Neuron, the study shows in animal models that glioblastoma hijacks the activity of neighboring brain cells…
Онкология
What Changes in Breast Oncology After ESMO 2026? The Trials, Treatment Shifts, and Unanswered Questions Shaping Clinical Practice
What Changes in Breast Oncology After ESMO 2026? The Trials, Treatment Shifts, and Unanswered Questions Shaping Clinical Practice Oncodaily
‹
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
›